Literature DB >> 31521630

Tau-induced mitochondrial membrane perturbation is dependent upon cardiolipin.

Angelique Camilleri1, Stephanie Ghio1, Mario Caruana1, Daniel Weckbecker2, Felix Schmidt3, Frits Kamp4, Andrei Leonov5, Sergey Ryazanov6, Christian Griesinger6, Armin Giese3, Ruben J Cauchi1, Neville Vassallo7.   

Abstract

Misfolding and aggregate formation by the tau protein has been closely related with neurotoxicity in a large group of human neurodegenerative disorders, which includes Alzheimer's disease. Here, we investigate the membrane-active properties of tau oligomers on mitochondrial membranes, using minimalist in vitro model systems. Thus, exposure of isolated mitochondria to oligomeric tau evoked a disruption of mitochondrial membrane integrity, as evidenced by a combination of organelle swelling, efflux of cytochrome c and loss of the mitochondrial membrane potential. Tau-induced mitochondrial dysfunction occurred independently of the mitochondrial permeability transition (mPT) pore complex. Notably, mitochondria were rescued by pre-incubation with 10-N-nonyl acridine orange (NAO), a molecule that specifically binds cardiolipin (CL), the signature phospholipid of mitochondrial membranes. Additionally, NAO prevented direct binding of tau oligomers to isolated mitochondria. At the same time, tau proteins exhibited high affinity to CL-enriched membranes, whilst permeabilisation of lipid vesicles also strongly correlated with CL content. Intriguingly, using single-channel electrophysiology, we could demonstrate the formation of non-selective ion-conducting tau nanopores exhibiting multilevel conductances in mito-mimetic bilayers. Taken together, the data presented here advances a scenario in which toxic cytosolic entities of tau protein would target mitochondrial organelles by associating with their CL-rich membrane domains, leading to membrane poration and compromised mitochondrial structural integrity.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiolipin; Membrane permeabilisation; Mitochondria; Nanopores; Oligomers; Tau

Mesh:

Substances:

Year:  2019        PMID: 31521630     DOI: 10.1016/j.bbamem.2019.183064

Source DB:  PubMed          Journal:  Biochim Biophys Acta Biomembr        ISSN: 0005-2736            Impact factor:   3.747


  9 in total

Review 1.  Cardiolipin, Mitochondria, and Neurological Disease.

Authors:  Micol Falabella; Hilary J Vernon; Michael G Hanna; Steven M Claypool; Robert D S Pitceathly
Journal:  Trends Endocrinol Metab       Date:  2021-02-24       Impact factor: 12.015

2.  Mitochondria as intracellular signaling platforms in health and disease.

Authors:  Jay X Tan; Toren Finkel
Journal:  J Cell Biol       Date:  2020-05-04       Impact factor: 10.539

Review 3.  Tau Oligomers Neurotoxicity.

Authors:  Grazyna Niewiadomska; Wiktor Niewiadomski; Marta Steczkowska; Anna Gasiorowska
Journal:  Life (Basel)       Date:  2021-01-06

Review 4.  The Role of Mitochondrial Impairment in Alzheimer´s Disease Neurodegeneration: The Tau Connection.

Authors:  Rodrigo A Quntanilla; Carola Tapia-Monsalves
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

5.  Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial.

Authors:  Johannes Levin; Nand Sing; Sue Melbourne; Amber Morgan; Carla Mariner; Maria Grazia Spillantini; Michal Wegrzynowicz; Jeffrey W Dalley; Simon Langer; Sergey Ryazanov; Andrei Leonov; Christian Griesinger; Felix Schmidt; Daniel Weckbecker; Kai Prager; Torsten Matthias; Armin Giese
Journal:  EBioMedicine       Date:  2022-04-29       Impact factor: 11.205

Review 6.  Oligomeropathies, inflammation and prion protein binding.

Authors:  Gianluigi Forloni; Pietro La Vitola; Claudia Balducci
Journal:  Front Neurosci       Date:  2022-08-23       Impact factor: 5.152

Review 7.  Steps Towards Developing Effective Treatments for Neuropsychiatric Disturbances in Alzheimer's Disease: Insights From Preclinical Models, Clinical Data, and Future Directions.

Authors:  Amalie Clement; Ove Wiborg; Ayodeji A Asuni
Journal:  Front Aging Neurosci       Date:  2020-03-06       Impact factor: 5.750

8.  Toxic oligomers of the amyloidogenic HypF-N protein form pores in mitochondrial membranes.

Authors:  Maria Ylenia Farrugia; Mario Caruana; Stephanie Ghio; Angelique Camilleri; Claude Farrugia; Ruben J Cauchi; Sara Cappelli; Fabrizio Chiti; Neville Vassallo
Journal:  Sci Rep       Date:  2020-10-20       Impact factor: 4.379

Review 9.  Membrane Interactions and Toxicity by Misfolded Protein Oligomers.

Authors:  Mario Gonzalez-Garcia; Giuliana Fusco; Alfonso De Simone
Journal:  Front Cell Dev Biol       Date:  2021-03-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.